PineBridge Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.6M Buy
933,316
+247,127
+36% +$14.4M 0.48% 45
2025
Q4
$37M Sell
686,189
-282,644
-29% -$13.6M 0.27% 72
2025
Q3
$43.7M Sell
968,833
-242,506
-20% -$11.3M 0.32% 69
2025
Q2
$56.1M Buy
1,211,339
+1,092,760
+922% +$53.6M 0.45% 40
2025
Q1
$7.23M Buy
118,579
+32,442
+38% +$1.89M 0.06% 260
2024
Q4
$4.87M Sell
86,137
-1,130,303
-93% -$63.2M 0.04% 312
2024
Q3
$62.9M Sell
1,216,440
-164,868
-12% -$7.73M 0.47% 43
2024
Q2
$57.4M Sell
1,381,308
-233,999
-14% -$10.5M 0.46% 39
2024
Q1
$87.6M Sell
1,615,307
-232,622
-13% -$11.9M 0.7% 22
2023
Q4
$94.8M Buy
1,847,929
+772,635
+72% +$40.6M 0.88% 19
2023
Q3
$62.4M Buy
1,075,294
+329,978
+44% +$20.2M 0.69% 21
2023
Q2
$47.7M Buy
745,316
+114,830
+18% +$7.7M 0.51% 39
2023
Q1
$43.7M Sell
630,486
-28,055
-4% -$1.98M 0.49% 46
2022
Q4
$47.4M Buy
658,541
+79,034
+14% +$5.96M 0.57% 39
2022
Q3
$41.2M Buy
579,507
+95,111
+20% +$6.9M 0.53% 40
2022
Q2
$37.3M Buy
484,396
+262,382
+118% +$20M 0.47% 49
2022
Q1
$16.2M Sell
222,014
-186,329
-46% -$12.5M 0.17% 142
2021
Q4
$25.5M Buy
408,343
+15,347
+4% +$900K 0.26% 90
2021
Q3
$23.3M Buy
392,996
+44,274
+13% +$2.92M 0.28% 96
2021
Q2
$23.3M Sell
348,722
-13,686
-4% -$892K 0.27% 90
2021
Q1
$22.9M Buy
362,408
+4,993
+1% +$311K 0.29% 80
2020
Q4
$22.2M Sell
357,415
-60,884
-15% -$3.74M 0.34% 69
2020
Q3
$25.2M Buy
418,299
+28,374
+7% +$1.71M 0.44% 50
2020
Q2
$22.9M Sell
389,925
-40,917
-9% -$2.45M 0.44% 57
2020
Q1
$24M Sell
430,842
-19,363
-4% -$1.18M 0.56% 37
2019
Q4
$28.9M Buy
450,205
+5,008
+1% +$287K 0.44% 51
2019
Q3
$22.6M Sell
445,197
-195,924
-31% -$9.21M 0.37% 64
2019
Q2
$29.1M Buy
641,121
+67,027
+12% +$3.12M 0.47% 57
2019
Q1
$27.4M Buy
574,094
+141,205
+33% +$7.03M 0.56% 45
2018
Q4
$22.5M Sell
432,889
-25,776
-6% -$1.38M 0.5% 54
2018
Q3
$28.5M Buy
458,665
+156,041
+52% +$9.26M 0.54% 48
2018
Q2
$16.7M Buy
302,624
+299,997
+11,420% +$16.2M 0.41% 62
2018
Q1
$167K Buy
2,627
+685
+35% +$44.1K ﹤0.01% 906
2017
Q4
$119K Buy
1,942
+416
+27% +$26K ﹤0.01% 939
2017
Q3
$97K Sell
1,526
-2,791
-65% -$163K ﹤0.01% 953
2017
Q2
$240K Sell
4,317
-16
-0.4% -$871 0.01% 763
2017
Q1
$236K Sell
4,333
-8,453
-66% -$464K 0.01% 762
2016
Q4
$747K Buy
12,786
+4,933
+63% +$270K 0.02% 511
2016
Q3
$423K Sell
7,853
-1,851
-19% -$119K 0.02% 305
2016
Q2
$714K Buy
9,704
+3,405
+54% +$241K 0.04% 246
2016
Q1
$402K Buy
6,299
+5,736
+1,019% +$362K 0.02% 318
2015
Q4
$39K Sell
563
-478
-46% -$31.6K ﹤0.01% 990
2015
Q3
$62K Buy
+1,041
New +$66K ﹤0.01% 883
2015
Q2
Sell
-1,194
Closed -$77K 1106
2015
Q1
$77K Sell
1,194
-9,883
-89% -$619K ﹤0.01% 950
2014
Q4
$654K Sell
11,077
-856
-7% -$48.3K 0.02% 342
2014
Q3
$611K Sell
11,933
-94,872
-89% -$4.74M 0.03% 320
2014
Q2
$5.18M Sell
106,805
-109,824
-51% -$5.41M 0.21% 132
2014
Q1
$11.3M Buy
216,629
+194,282
+869% +$10.3M 0.37% 92
2013
Q4
$1.19M Sell
22,347
-7,257
-25% -$370K 0.04% 302
2013
Q3
$1.37M Buy
29,604
+2
+0% +$88 0.04% 288
2013
Q2
$1.32M Buy
+29,602
New +$1.29M 0.04% 297

Other funds holding BMY

PineBridge Investments's BMY Position: Q1 2026 in Review

PineBridge Investments increased its Bristol-Myers Squibb (BMY) stake by 36% in Q1 2026, buying an estimated $14.4M and bringing the position to 933,316 shares worth $56.6M. The position accounts for 0.48% of the portfolio, ranked #45.

PineBridge Investments first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $94.8M in Q4 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • PineBridge Investments held 933,316 shares of Bristol-Myers Squibb worth $56.6M as of Q1 2026.
  • PineBridge Investments bought 247,127 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.4M.
  • Bristol-Myers Squibb made up 0.48% of PineBridge Investments's portfolio in Q1 2026, its #45 holding.
  • PineBridge Investments first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
  • PineBridge Investments's Bristol-Myers Squibb position peaked at $94.8M in Q4 2023.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on PineBridge Investments's 13F filing for Q1 2026, filed 14 May 2026.